CSL profits from National rollout as swine flu vaccine approved

Excerpt from The Age 18 September 2009

Ms Roxon was unable to put a precise figure on the cost of the vaccine.

"There are some confidentiality issues. We have a private contractual agreement with CSL for the priority provision for this vaccine," she said.

"I have made clear on the record before that it is over $100 million. It is not appropriate for us to be itemising the exact cost, given the commercial interests that are also at stake."

ref: http://www.theage.com.au/national/national-rollout-as-swine-flu-vaccine-approved-20090918-fuyz.html